Dr. Andrew Feinberg, Bloomberg Distinguished Professor of Epigenetics at Johns Hopkins University Schools of Medicine, Engineering and Public Health, has been awarded the 2026 AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research.
The award, recognizing individuals who make outstanding accomplishments in basic research, was established in 1961 to honor Dr. G.H.A. Clowes, a founding member of the American Association for Cancer Research (AACR) and a research director at the pharmaceutical company, Lilly.
Feinberg is the director of the Johns Hopkins Center for Epigenetics in the Institute for Basic Biomedical Sciences and director of the Division of Molecular Medicine in the Department of Medicine at Johns Hopkins Medicine.
The award recognizes Feinberg’s pioneering work in establishing the key role of epigenetic alterations in cancer. His research demonstrated that epigenetic changes, where methyl groups latch on to DNA, contribute to the growth and progression of tumors. AACR notes that his contributions “…established the epigenome as a central driver of cancer biology, identified causal epigenetic mechanisms for cancer risk and progression, and laid the foundation for new approaches to cancer detection, prevention, and therapeutic intervention.”
As part of the award, Feinberg will deliver a lecture at the AACR annual meeting in San Diego on Monday, April 20, at 5:30 p.m., PT.
